America February 23, 2026
Gilead to Acquire Arcellx in $7.8B Biotech Bet on Cancer Therapy
In a high-stakes move that could reshape the cancer treatment landscape, Gilead to acquire Arcellx became the headline Monday as…
America February 23, 2026
In a high-stakes move that could reshape the cancer treatment landscape, Gilead to acquire Arcellx became the headline Monday as…
By Rihem Akkouche
America February 19, 2026
In a bold move aimed at redrawing the map of digital health, Hims & Hers Health said Thursday it will…
By Rihem Akkouche
America December 3, 2025
Seven states — California, Michigan, New York, Maryland, Massachusetts, Connecticut, and Tennessee — have moved to intervene in a sweeping…
By Rihem Akkouche
America November 14, 2025
A proposed class of consumers has filed suit against ByHeart Inc., alleging the baby-formula maker concealed contamination with Clostridium botulinum—a…
By Rihem Akkouche
America November 5, 2025
The courtroom battle over J&J and Kenvue IPO Fraud Claims intensified this week after a federal judge refused to reconsider…
By Rihem Akkouche
America October 23, 2025
Colgate-Palmolive Co. is facing a proposed class-action lawsuit in California federal court, accused of selling its children’s “hello” brand toothpaste…
By Rihem Akkouche
America September 18, 2025
The First Circuit on Wednesday shut down the Trump administration’s attempt to slash 10,000 jobs at the U.S. Department of…
By Rihem Akkouche
America June 16, 2025
In a bold bid to dominate the neuropsychiatric treatment space, Supernus Pharmaceuticals Inc. announced Monday that it will acquire Sage…
By Rihem Akkouche
America March 27, 2025
In a seismic shift that will reshape the landscape of federal health agencies, the U.S. Department of Health and Human…
By Rihem Akkouche
America February 13, 2025
In a razor-thin 52-48 vote, the U.S. Senate confirmed Robert F. Kennedy Jr. as the new Secretary of Health and…
By Rihem Akkouche